Weber, ChristianFreimark, DenisePortner, RalfPino-Grace, PabloPohl, SebastianWallrapp, ChristineGeigle, PeterCzermak, Peter2011-04-212011-04-212018-04-03http://hdl.handle.net/2097/8441Human mesenchymal stem cells (hMSC) are a promising cell source for the manufacturing of cell therapeutic or tissue engineered implants. In part A of this publication a fixed-bed bioreactor system based on non-porous borosilicate glass spheres and procedures for the automated expansion of hMSC with high yield and vitality has been introduced. Part B of this study deals with the modeling of the process in order to transfer the bioreactors system from the laboratory to the production scale. Relevant model parameters have been obtained by fitting them to the experimental data of hMSC-TERT cultivations in scales up to 300 cm3. Scale-up calculations were carried out exemplarily for a target cell number of twenty billion cells.This Item is protected by copyright and/or related rights. You are free to use this Item in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you need to obtain permission from the rights-holder(s).Mesenchymal stem cellshMSC-TERTFixed-bed bioreactorGlass carrierScale upText